The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) is a spectrum comprised of isolated steatosis, nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. The majority of NAFLD subjects do not have NASH and do not carry a significant risk for liver-related adverse outcomes (cirrhosis and mortality). Globally, the prevalence of NAFLD is approximately 25%. In Asia, a gradient of high to low prevalence rates is noted from urban to rural areas. Given the prevalence of NAFLD, the clinical and economic burden of NAFLD and NASH can be substantial. With increasing recognition of NASH as an important liver disease, the diagnosis of NASH still requires a liver biopsy that is suboptimal. Although liver biopsy is the most accurate modality to diagnose and stage the severity of NASH, this method suffers from being invasive, costly, associated with potential complications, and plagued with interobserver variability of individual pathological features. A number of noninvasive modalities to diagnose NASH and stage liver fibrosis are being developed. These modalities include predictive models (NAFLD fibrosis score) and serum biomarkers such as enhanced liver fibrosis (ELF). Other tests are based on radiological techniques, such as transient elastography (TE) or magnetic resonance elastography (MRE), which are used to estimate liver stiffness as a potential surrogate of hepatic fibrosis. Although a dynamic field of research, most of these diagnostic modalities have area under the curve ranging between 0.76 and 0.90%, with MRE having the best predictive performance. In summary, developing safe and easily accessible noninvasive modalities to accurately diagnose and monitor NASH and associated fibrosis is of utmost importance in clinical practice and clinical research. These tests are not only important to risk stratify subjects at the greatest risk for progressive liver disease, but also to serve as appropriate surrogate endpoints for therapeutic clinical trials of NASH. (Hepatology 2018;68:349-360).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Self-citationYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Self-citationChalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Self-citationNonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Self-citationAngulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
Self-citationAngulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287 · cited 1×
“Given that stage of fibrosis is the most important predictor of outcome,((7,8,10,68)) much effort has focused on determining presence of fibrosis.”
BackgroundThe utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Self-citationDulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
Self-citationWong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Self-citationComparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Shah, A. G., Lydecker, A., Murray, K., Tetri, B. N., Contos, M. J., & Sanyal, A. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.033 · Cited by 1,553
Self-citationPrevalence of Fatty Liver in Children and Adolescents
Schwimmer, J. B., Deutsch, R., Kahen, T., Lavine, J. E., Stanley, C., & Behling, C. (2006) · Pediatrics · doi:10.1542/peds.2006-1212 · Cited by 1,481
Self-citationThe economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Younossi, Z. M., Blissett, D., Blissett, R., Henry, L., Stepanova, M., Younossi, Y., Racila, A., Hunt, S., & Beckerman, R. (2016) · Hepatology · doi:10.1002/hep.28785 · Cited by 1,285
Self-citationSerum markers detect the presence of liver fibrosis: A cohort study
Rosenberg, W. M. C., Voelker, M., Thiel, R., Becka, M., Burt, A., Schuppan, D., Hubscher, S., Roskams, T., Pinzani, M., & Arthur, M. J. P. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.052 · Cited by 1,102
McPherson, S., Stewart, S. F., Henderson, E., Burt, A. D., & Day, C. P. (2010) · Gut · doi:10.1136/gut.2010.216077 · Cited by 946
Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis
McPherson, S., Hardy, T., Dufour, J.-F., Petta, S., Romero-Gomez, M., Allison, M., Oliveira, C. P., Francque, S., Van Gaal, L., Schattenberg, J. M., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.453 · Cited by 945
Self-citationThe natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Imajo, K., Kessoku, T., Honda, Y., Tomeno, W., Ogawa, Y., Mawatari, H., Fujita, K., Yoneda, M., Taguri, M., Hyogo, H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.11.048 · Cited by 812
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Guha, I. N., Parkes, J., Roderick, P., Chattopadhyay, D., Cross, R., Harris, S., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., et al. (2008) · Hepatology · doi:10.1002/hep.21984 · Cited by 745
Feldstein, A. E., Wieckowska, A., Lopez, R. A., Liu, Y.-C., Zein, N. N., & McCullough, A. J. (2009) · Hepatology · doi:10.1002/hep.23050 · Cited by 712
Park, C. C., Nguyen, P., Hernandez, C., Bettencourt, R., Ramirez, K., Fortney, L., Hooker, J., Sy, E., Savides, M. T., Alquiraish, M. H., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.026 · Cited by 708
Self-citationYounossi, Z. M., Stepanova, M., Rafiq, N., Makhlouf, H., Younoszai, Z., Agrawal, R., & Goodman, Z. (2011) · Hepatology · doi:10.1002/hep.24268 · Cited by 638
Self-citationGoldberg, D., Ditah, I. C., Saeian, K., Lalehzari, M., Aronsohn, A., Gorospe, E. C., & Charlton, M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.003 · Cited by 604
Self-citationPirola, C. J., Fernández Gianotti, T., Castaño, G. O., Mallardi, P., San Martino, J., Mora Gonzalez Lopez Ledesma, M., Flichman, D., Mirshahi, F., Sanyal, A. J., & Sookoian, S. (2015) · Gut · doi:10.1136/gutjnl-2014-306996 · Cited by 564
Self-citationNoureddin, M., Lam, J., Peterson, M. R., Middleton, M., Hamilton, G., Le, T.-A., Bettencourt, R., Changchien, C., Brenner, D. A., Sirlin, C., et al. (2013) · Hepatology · doi:10.1002/hep.26455 · Cited by 550
Self-citationRatziu, V., Massard, J., Charlotte, F., Messous, D., Imbert-Bismut, F., Bonyhay, L., Tahiri, M., Munteanu, M., Thabut, D., Cadranel, J. F., et al. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-6 · Cited by 492
Self-citationBoursier, J., Vergniol, J., Guillet, A., Hiriart, J.-B., Lannes, A., Le Bail, B., Michalak, S., Chermak, F., Bertrais, S., Foucher, J., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.023 · Cited by 400
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Argo, C. K., & Caldwell, S. H. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.005 · Cited by 389
Self-citationDulai, P. S., Sirlin, C. B., & Loomba, R. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.005 · Cited by 356
Self-citationOni, E. T., Agatston, A. S., Blaha, M. J., Fialkow, J., Cury, R., Sposito, A., Erbel, R., Blankstein, R., Feldman, T., Al-Mallah, M. H., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.052 · Cited by 352
Permutt, Z., Le, T. ‐., Peterson, M. R., Seki, E., Brenner, D. A., Sirlin, C., & Loomba, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05121.x · Cited by 346
Self-citationLoomba, R., Sirlin, C. B., Ang, B., Bettencourt, R., Jain, R., Salotti, J., Soaft, L., Hooker, J., Kono, Y., Bhatt, A., et al. (2015) · Hepatology · doi:10.1002/hep.27647 · Cited by 344
Self-citationNonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.
Younossi, Z. M., Gramlich, T., Liu, Y. C., Matteoni, C. A., Petrelli, M., Goldblum, J. R., Rybicki, L. A., & McCullough, A. J. (1998) · PubMed · Cited by 321
Self-citationVerma, S., Jensen, D., Hart, J., & Mohanty, S. R. (2013) · Liver International · doi:10.1111/liv.12226 · Cited by 314
Kleiner, D. E., & Makhlouf, H. R. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.011 · Cited by 303
Feldstein, A. E., Lopez, R., Tamimi, T. A.-R., Yerian, L., Chung, Y.-M., Berk, M., Zhang, R., McIntyre, T. M., & Hazen, S. L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m007096 · Cited by 297
Cusi, K., Chang, Z., Harrison, S., Lomonaco, R., Bril, F., Orsak, B., Ortiz-Lopez, C., Hecht, J., Feldstein, A. E., Webb, A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.042 · Cited by 273
Self-citationNoninvasive evaluation of NAFLD
Castera, L., Vilgrain, V., & Angulo, P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.175 · Cited by 273
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
Anstee, Q. M., Seth, D., & Day, C. P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.037 · Cited by 254
Self-citationLe, T.-A., Chen, J., Changchien, C., Peterson, M. R., Kono, Y., Patton, H., Cohen, B. L., Brenner, D., Sirlin, C., & Loomba, R. (2012) · Hepatology · doi:10.1002/hep.25731 · Cited by 243
Self-citationObesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression
Barr, J., Caballería, J., Martínez-Arranz, I., Domínguez-Díez, A., Alonso, C., Muntané, J., Pérez-Cormenzana, M., García-Monzón, C., Mayo, R., Martín-Duce, A., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr201223p · Cited by 226
Hardy, T., Zeybel, M., Day, C. P., Dipper, C., Masson, S., McPherson, S., Henderson, E., Tiniakos, D., White, S., French, J., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311526 · Cited by 216 · cited 1×
“Mounting evidence indicates that epigenetic factors, such as differential DNA methylation and circulating cell-free DNA methylation signatures in plasma, may potentially stratify patients with NAFLD into mild versus severe fibrosis.((83,84)) miRNA is another genetic marker that appears to be relatively stable and can…”
BackgroundSelf-citationPalekar, N. A., Naus, R., Larson, S. P., Ward, J., & Harrison, S. A. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01209.x · Cited by 216
Self-citationHepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study
Mellinger, J. L., Pencina, K. M., Massaro, J. M., Hoffmann, U., Seshadri, S., Fox, C. S., O’Donnell, C. J., & Speliotes, E. K. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.045 · Cited by 212
Loomba, R., Cui, J., Wolfson, T., Haufe, W., Hooker, J., Szeverenyi, N., Ang, B., Bhatt, A., Wang, K., Aryafar, H., et al. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.65 · Cited by 202
Self-citationLoomba, R., Quehenberger, O., Armando, A., & Dennis, E. A. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p055640 · Cited by 197
Self-citationCui, J., Heba, E., Hernandez, C., Haufe, W., Hooker, J., Andre, M. P., Valasek, M. A., Aryafar, H., Sirlin, C. B., & Loomba, R. (2016) · Hepatology · doi:10.1002/hep.28337 · Cited by 191
Self-citationNonalcoholic fatty liver disease: What nurses need to know
(2020) · Nursing · doi:10.1097/01.nurse.0000656496.00204.01 · Cited by 179
Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography
Pinzani, M., Vizzutti, F., Arena, U., & Marra, F. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1025 · Cited by 178
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease
Khov, N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i22.6821 · Cited by 177
Chen, J., Yin, M., Talwalkar, J. A., Oudry, J., Glaser, K. J., Smyrk, T. C., Miette, V., Sandrin, L., & Ehman, R. L. (2017) · Radiology · doi:10.1148/radiol.2016160685 · Cited by 175
Adams, L. A., George, J., Bugianesi, E., Rossi, E., De Boer, W. B., van der Poorten, D., Ching, H. L. I., Bulsara, M., & Jeffrey, G. P. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06774.x · Cited by 172
Self-citationAnty, R., Iannelli, A., Patouraux, S., Bonnafous, S., Lavallard, V., Buratti, M. S., Amor, I. B., Staccini-Myx, A., Saint‐Paul, M., Berthier, F., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04480.x · Cited by 171
Younossi, Z. M., Otgonsuren, M., Venkatesan, C., & Mishra, A. (2013) · Metabolism · doi:10.1016/j.metabol.2012.08.005 · Cited by 169
Self-citationTan, Y., Ge, G., Pan, T., Wen, D., & Gan, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105192 · Cited by 169
Tapper, E. B., Challies, T., Nasser, I., Afdhal, N. H., & Lai, M. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.49 · Cited by 164
Shimada, M., Kawahara, H., Ozaki, K., Fukura, M., Yano, H., Tsuchishima, M., Tsutsumi, M., & Takase, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01322.x · Cited by 163
A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
Younossi, Z. M., Page, S., Rafiq, N., Birerdinc, A., Stepanova, M., Hossain, N., Afendy, A., Younoszai, Z., Goodman, Z., & Baranova, A. (2011) · Obesity Surgery · doi:10.1007/s11695-010-0204-1 · Cited by 162
Self-citationBidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome
Wainwright, P., & Byrne, C. D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030367 · Cited by 162
Assessment of abdominal adipose tissue and organ fat content by magnetic resonance imaging
Hu, H., Nayak, K. S., & Goran, M. I. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00824.x · Cited by 144
Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
Younossi, Z. M., Stepanova, M., Rafiq, N., Henry, L. L., Loomba, R. S., Makhlouf, H. R., & Goodman, Z. D. (2017) · Hepatology Communications · doi:10.1002/hep4.1054 · Cited by 137
Self-citationMallory body—A disease-associated type of sequestosome
Stumptner, C., Fuchsbichler, A., Heid, H., Zatloukal, K., & Denk, H. (2002) · Hepatology · doi:10.1053/jhep.2002.32674 · Cited by 135
Lonardo, A., Ballestri, S., Guaraldi, G., Nascimbeni, F., Romagnoli, D., Zona, S., & Targher, G. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i44.9674 · Cited by 135
Tanwar, S., Trembling, P. M., Guha, I. N., Parkes, J., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., Day, C. P., & Rosenberg, W. M. (2012) · Hepatology · doi:10.1002/hep.26030 · Cited by 126
Younossi, Z. M., Stepanova, M., Henry, L. L., Racila, A., Lam, B. P., Phạm, T. T. H., & Hunt, S. (2017) · Liver International · doi:10.1111/liv.13391 · Cited by 113
Self-citationDecaris, M. L., Li, K. W., Emson, C. L., Gatmaitan, M., Liu, S., Wang, Y., Nyangau, E., Colangelo, M., Angel, T. E., Beysen, C., et al. (2016) · Hepatology · doi:10.1002/hep.28860 · Cited by 101
Self-citationZarrinpar, A., Gupta, S., Maurya, M. R., Subramaniam, S., & Loomba, R. (2016) · Gut · doi:10.1136/gutjnl-2015-309456 · Cited by 88
Self-citationNon-alcoholic fatty liver disease: non-invasive investigation and risk stratification
Dyson, J. K., McPherson, S., & Anstee, Q. M. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201620 · Cited by 82
Self-citationSayıner, M., Stepanova, M., Phạm, T. T. H., Noor, B., Walters, M., & Younossi, Z. M. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000106 · Cited by 82
Self-citationKarsdal, M. A., Henriksen, K., Nielsen, M. J., Byrjalsen, I., Leeming, D. J., Gardner, S. D., Goodman, Z. D., Patel, K., Krag, A. A., Christiansen, C., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00283.2016 · Cited by 82
Self-citationSayiner, M., Otgonsuren, M., Cable, R., Younossi, I., Afendy, M., Golabi, P., Henry, L., & Younossi, Z. M. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000567 · Cited by 76
Self-citationControversies in the Diagnosis and Management of NAFLD and NASH.
Rinella, M. E., Loomba, R. S., Caldwell, S. H., Kowdley, K. V., Charlton, M., Tetri, B. A., & Harrison, S. A. (2014) · PubMed · Cited by 74
Self-citationNonalcoholic Fatty Liver Disease: A Practical Approach to Evaluation and Management
Rafiq, N., & Younossi, Z. M. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.02.009 · Cited by 72
Self-citationSiddiqui, M. S., Patidar, K. R., Boyett, S. L., Luketic, V. A., Puri, P., & Sanyal, A. J. (2015) · Liver International · doi:10.1111/liv.13054 · Cited by 54
Self-citationOxNASH Score Correlates with Histologic Features and Severity of Nonalcoholic Fatty Liver Disease
Alkhouri, N., Berk, M. P., Yerian, L. M., López, R., Chung, Y. M., Zhang, R., McIntyre, T. M., Feldstein, A. E., & Hazen, S. L. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3031-8 · Cited by 49
Younossi, Z. M., Zheng, L., Stepanova, M., Henry, L. L., Venkatesan, C., & Mishra, A. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000071 · Cited by 49
Self-citationNon-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease
Altamirano, J., Qi, Q., Choudhry, S., Abdallah, M., Singal, A. K., Humar, A., Bataller, R. A., Borhani, A. A., & Duarte‐Rojo, A. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.11.14 · Cited by 46
Younossi, Z. M. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.05.029 · Cited by 32
Self-citationNon-Invasive Diagnostic Tests for Non-Alcoholic Fatty Liver Disease
Estep, M., Birerdinc, A., & Younossi, Z. M. (2010) · Current Molecular Medicine · doi:10.2174/156652410790963321 · Cited by 30
Self-citationNoninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease
Jayakumar, S., Harrison, S. A., & Loomba, R. S. (2016) · Current Hepatology Reports · doi:10.1007/s11901-016-0296-8 · Cited by 28
Self-citationNonalcoholic Fatty Liver Disease
Gawrieh, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_14 · Cited by 25
İdilman, İ. S., Keskın, O., Elhan, A. H., Idılman, R., & Karçaaltıncaba, M. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.894118 · Cited by 24
Caution in Using Non-Invasive Scoring Systems in NAFLD Beyond Highly Selected Study Populations
Armstrong, M. J., Schmidt-Martin, D., Rowe, I. A. C., & Newsome, P. N. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.28 · Cited by 5
Cited by
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Castera, L., Friedrich-Rust, M., & Loomba, R. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.036 · Cited by 1,494
Self-citationNonalcoholic Fatty Liver Disease 2020: The State of the Disease
Cotter, T. G., & Rinella, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.052 · Cited by 1,198
Self-citationCusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Self-citationEASL Clinical Practice Guidelines: Management of alcohol-related liver disease
Thursz, M., Gual, A., Lackner, C., Mathurin, P., Moreno, C., Spahr, L., Sterneck, M., & Cortez-Pinto, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.018 · Cited by 943
Self-citationStefan, N., Häring, H.-U., & Cusi, K. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 837
Metadata
- Authors
- Younossi, Z. M., Loomba, R., Anstee, Q. M., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander‐Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., Ratziu, V., Corey, K. E., Friedman, S. L., Abdelmalek, M. F., Harrison, S. A., Sanyal, A. J., Lavine, J. E., Mathurin, P., Charlton, M. R., Goodman, Z. D., Chalasani, N. P., Kowdley, K. V., George, J., & Lindor, K.
- Venue
- Hepatology
- Published
- 2018-07
- Volume
- 68
- Issue
- 1
- Pages
- 349-360
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2774672890
- Cited by
- 431
- References
- 85
- FWCI
- 31.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.